新闻Numerate, Inc. receives financing of $2M in Small Business Innovation Research.Numerate, Inc., a San Bruno, CA-based computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, received a $2m Small Business Innovation Research (SBIR) Phase II grant.
新闻Numerate, Inc. partners with CUBRC.Under the contract Numerate will be extending the capabilities of and, in collaboration with CUBRC, validating and deploying its ToxTool system, developed and validated with CUBRC under two previous contracts with DTRA (under Prime Contracts FA8075-14-C-0092 and SP00700-00D-3180).
新闻Takeda Pharmaceuticals partnered with Numerate, Inc. on Jun 1st '17.The search for partners with unique drug discovery capabilities prompted Takeda to enter into an alliance with Numerate.
